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STUDY QUESTION: Do human trophoblast cells modulate neutrophil extracellular trap (NET) formation, reactive oxygen species (ROS)
synthesis and neutrophil apoptosis through mechanisms involving vasoactive intestinal peptide (VIP)?
SUMMARY ANSWER: Trophoblast cells inhibited NET formation and ROS synthesis and enhanced neutrophil apoptosis through VIP-
mediated pathways in a model of maternal–placental interaction.
WHAT IS KNOWN ALREADY: Immune homeostasis maintenance at the maternal–placental interface is mostly coordinated by tropho-
blast cells. Neutrophil activation and NET formation increases in pregnancies complicated by exacerbated pro-inflammatory responses. VIP
has anti-inflammatory and immunosuppressant effects and is synthesized by trophoblast cells.
STUDY DESIGN, SIZE, DURATION: This is a laboratory-based observational study that sampled circulating neutrophils from 50 healthy
volunteers to explore their response in vitro to factors derived from human trophoblast cells.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Peripheral blood neutrophils were isolated from healthy volunteers and
tested in vitro with first trimester trophoblast cell line (Swan-71 and HTR8) conditioned media (CM) or with VIP. The effect of VIP and
trophoblast CM on NET formation was assessed by co-localization of elastase and DNA by confocal microscopy, DNA release and elastase
activity measurement. Neutrophil apoptosis was determined by flow cytometry or fluorescence microscopy. ROS formation was assessed by
flow cytometry with a fluorescent probe. VIP silencing was performed by siRNA transfection. For phagocytosis of apoptotic neutrophils,
autologous monocytes were sampled, and engulfment and cytokines were assessed by flow cytometry and ELISA.
MAIN RESULTS AND THE ROLE OF CHANCE: Trophoblast CM and 10 nM VIP promoted neutrophil deactivation by preventing
phorbol myristate acetate–induced NET formation and ROS synthesis while they increased neutrophil spontaneous apoptosis and reversed
the anti-apoptotic effect of lipopolysaccharide (all P < 0.05 versus control). The effects of trophoblast CM were prevented by a VIP antagonist
or when VIP knocked-down trophoblast cells were used (P < 0.05 versus control). Neutrophils driven to apoptosis by trophoblast CM could
be rapidly engulfed by monocytes without increasing IL-12 production.
LARGE SCALE DATA: Not applicable.
LIMITATIONS, REASONS FOR CAUTION: The mechanisms of neutrophil deactivation by trophoblast VIP are based on the results
obtained with neutrophils drawn from peripheral blood of healthy individuals interacting with trophoblast cell lines in vitro. These studies were
designed to investigate biological processes at the cellular and molecular level; therefore, they have the limitations of studies in vitro and it is
not possible to ascertain if these mechanisms operate similarly in vivo. We tested 50 neutrophil samples from healthy volunteers that have a
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.















normal variability in their responses. Cell lines derived from human trophoblast were used, and we cannot rule out a differential behavior of
trophoblast cells in contact with neutrophils in vivo.
WIDER IMPLICATIONS OF THE FINDINGS: Results presented here are consistent with an active mechanism through which neutro-
phils in contact with trophoblast cells would be deactivated and silently cleared by decidual macrophages throughout pregnancy. They sup-
port a novel immunomodulatory role of trophoblast VIP on neutrophils at the placenta, providing new clues for pharmacological targeting of
immune and trophoblast cells in pregnancy complications associated with exacerbated inflammation.
STUDY FUNDING/COMPETING INTERESTS: This work was funded by the National Agency of Sciences and Technology (PICT
2011-0144, 2014-0657 and 2013-2177) and University of Buenos Aires (UBACyT 20020130100040BA, 20020150100161BA and
20020130100744BA). The authors declare no competing interests.
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Introduction
The recruitment and functional shaping of different leukocyte popula-
tions at the early maternal–placental interface is orchestrated by
trophoblast cells ensuring normal placentation and immune homeosta-
sis maintenance (Racicot et al., 2014). Consistently, in pregnancies
complicated by preeclampsia, an exacerbated pro-inflammatory
response arises in the mother early in pregnancy with a vasculopathy
that threatens both maternal and fetal survival in the third trimester
(Sacks et al., 1998; Redman and Sargent, 2010).
In contrast to macrophages and natural killer cells recruited to the
pregnant uterus from the first weeks, neutrophils are barely found until
the second trimester where a novel pro-angiogenic decidual neutrophil
population has been identified (Amsalem et al., 2014). However, the
highest neutrophil influx to the pregnant uterus occurs near term,
associated with the pro-inflammatory response that prepares the
uterus for delivery (Gomez-Lopez et al., 2014). Chemokine (C-X-C
motif) ligand 8 (CXCL8 or IL-8), a chemokine released at high levels
by trophoblast cells, is one of the major cytokines that induce
NETosis, a distinct form of active cell death characterized by the
release of decondensed chromatin into the extracellular space with
granular and cytoplasmic proteins associated (Brinkmann et al., 2004;
Papayannopoulos and Zychlinsky, 2009). Neutrophils forming NETs
do not appear to display “eat-me” signals like apoptotic cells, which
would prevent their silent clearance by phagocytic cells (Kaplan and
Radic, 2012). In fact, when neutrophils undergoing NETosis are faced
to M2 alternative differentiated macrophages, a pro-inflammatory
mediator release is observed (Nakazawa et al., 2016). NETs have
been linked to the promotion of thrombosis as scaffolds for fibrin and
von Willebrand factor (Fuchs et al., 2010), and to the pathogenesis
of lupus nephritis (Hakkim et al., 2010) among other disorders.
Trophoblast microvesicles derived from placental syncytium in normal
pregnancies induce NET formation in vitro, and both IL-8 and tropho-
blast microvesicles were proposed as potential triggers of NET forma-
tion in preeclampsia (Gupta et al., 2005). On the basis that circulating
neutrophils from normal pregnant versus non-pregnant women syn-
thesize higher levels of reactive oxygen species (ROS) (Tsukimori
et al., 1993; Sacks et al., 1998; Aly et al., 2004) and that preeclamptic
placenta revealed massive presence of NETs largely localized within
the intervillous space (Gupta et al., 2005), it was proposed that neu-
trophils become activated during their circulation through the
intervillous space (Walsh and Wang, 1995; Mellembakken et al., 2002;
Hahn et al., 2012). However, evidence of placental-derived local fac-
tors that can modulate neutrophil activation and NET formation in
normal pregnancies is still lacking.
The vasoactive intestinal peptide (VIP) is a pleiotropic polypeptide
with vasodilating, pro-secretory and anti-inflammatory effects binding
upon high-affinity VPAC1 and VPAC2 receptors (Waschek, 2013). In
human pregnancy, VIP is synthesized by cytotrophoblast and syncytio-
trophoblast cells of the first and third trimester placenta as well as the
first trimester trophoblast-derived cell lines Swan-71 and HTR8
(Marzioni et al., 2005; Vota et al., 2016). VIP modulates trophoblast
cell function and their interaction with monocytes and macrophages to
promote immunosuppressive apoptotic cell phagocytosis (Paparini
et al., 2015; Vota et al., 2016). VPAC1 receptors are expressed on
neutrophils and VIP inhibits neutrophil cytotoxicity and superoxide
anion generation (Palermo et al., 1996; Harfi et al., 2004). On this
basis, we hypothesized that trophoblast cells modulate the functional
profile of neutrophils through VIP-mediated pathways to prevent NET
formation, induce neutrophil apoptosis and contribute to their silent
clearance. By means of an in vitro model of maternal–placental inter-
action, we explored the effects of trophoblast conditioned media
(CM) and VIP on NET formation, ROS synthesis and neutrophil apop-
tosis. We evaluated their ability as well to modulate apoptotic neutro-
phil phagocytosis by autologous monocytes. Our results demonstrate
that VIP from trophoblast cells inhibits neutrophil activation and NET
formation and accelerates neutrophil apoptosis. Moreover, neutro-
phils undergoing apoptosis in the presence of CM were more rapidly
phagocytosed without pro-inflammatory cytokine release, suggesting a
regulatory network mediated by trophoblast cells to prevent neutro-
phil activation throughout pregnancy.
Materials andMethods
Blood samples
Peripheral blood samples were obtained from 50 healthy volunteers who
were not under pharmacological treatment for at least 10 days before
sampling. Studies were approved by the Argentine Society of Clinical
Investigation Board and Ethical Committee (Ref. SAIC 46/14). All healthy
donors provided written informed consent for sample collection and sub-
sequent analysis.














Neutrophil and monocyte isolation
Neutrophils were isolated by Ficoll-Paque PLUS (GE Healthcare, Uppsala,
Sweden) gradient centrifugation and Dextran (MP Biomedicals, Santa Ana,
CA, USA) sedimentation. Contaminating erythrocytes were removed by
hypotonic lysis, and neutrophils were suspended in RPMI 1640 medium
supplemented with 10% heat-inactivated fetal bovine serum (FBS)
(Natocor, Villa Carlos Paz, Argentina). The purity was checked by flow
cytometry using an anti-CD14 antibody (BD Pharmingen, San Diego, CA,
USA) to guarantee a monocyte contamination <0.5% and that forward
scatter/side scatter parameters of the neutrophil population were com-
patible with those of non-activated cells. Cells were used immediately after
isolation. Monocytes were purified by Percoll (GE Healthcare) gradient
(>80% purity) as done earlier (Paparini et al., 2015).
Trophoblast-derived cell cultures
Swan-71 and HTR8/SVneo human first trimester cell lines were kindly
given by Dr Gil Mor (Yale University, New Haven, CT, USA). To obtain
trophoblast CM, cells were cultured for 20 h in RPMI 2% FBS with or with-
out 50 nM VIP antagonist (Bachem, CA, USA).
VIP silencing
Swan-71 cells were transfected with 50–100 nM VIP siRNA (Santa Cruz
Biotechnology, Dallas, TX, USA): Lipofectamine RNAimax (Life Technolo-
gies, Grand Island) complex as previously described (Vota et al., 2016).
Twenty-four hours post-transfection, the media were changed to DMEM-
F12 with 2% FBS for 48 h and then collected and stored at −20°C until
used. siRNA with a scramble sequence was used as a control.
Elastase activity and DNA determinations
After neutrophil stimulation with phorbol myristate acetate (PMA) for
210min, cells were treated for 30min with 1 U/ml micrococcal nuclease
(Roche Diagnostics, Mannheim, Germany), and supernatants were collected
to determine elastase activity and DNA concentration (Ramos et al., 2016).
Neutrophil elastase activity was measured spectrophotometrically at
Figure 1 Trophoblast conditioned media (CM) and vasoactive intestinal peptide (VIP) inhibit neutrophil extracellular trap (NET) formation.
Neutrophils were incubated with phorbol myristate acetate (PMA) and VIP or CM to analyze NET formation, DNA and elastase release as described
in Materials and Methods. (A) Neutrophils (1 × 106) were placed on coverslips and stimulated or not (Basal) with 20 or 40 ng/ml PMA, 10 nM VIP or
Swan-71 trophoblast cell CM, and NETs were detected by propidium iodide (PI) staining of DNA (red) and anti-elastase and secondary DyLight-488
antibody (green). Merged representative images of at least three experiments with different neutrophil donors are shown. Scale bars = 10 µm.
(B) Neutrophils (1 × 106) were incubated for 4 h with PMA and 10 nM VIP or CM and released DNA, or elastase activity were measured in the super-
natants. Results are mean ± SEM (*P < 0.05; n = 5, Wilcoxon test).














405/550 nm, using the specific peptide substrate N-Methoxysuccinyl-Ala-
Ala-Pro-Val (Sigma-Aldrich, St. Louis, MO, USA). DNA concentration was
determined fluorometrically with Sybr Gold (Invitrogen).
NETosis and confocal microscopy
Glass cover slides and Lab-Tek chambers were pretreated with Poly-L-
Lysine (Sigma-Aldrich), and then neutrophils were seeded. Four hours
post-PMA stimulation, cells were fixed with 4% paraformaldehyde
(Sigma-Aldrich) and NETs were detected using propidium iodide (PI) to
visualize DNA and an anti-elastase antibody (Calbiochem, Billerica, MA,
USA) with a secondary DyLight-488 (Jackson ImmunoResearch). In one
set of experiments, at 150 min post-PMA stimulation, cells were stained
with PI (Ramos et al., 2016) and neutrophils undergoing NETosis, apop-
tosis and viable cells were identified by examining nuclei morphology
and differential interference contrast signal. Viable neutrophils were
identified by a multilobulated nucleus, which stained brightly with PI;
apoptotic cells were characterized by their highly condensed nuclear
material into one to three very brightly PI-stained nuclear bodies and
cytoplasmic vacuolation (Taylor et al., 2007), while NETotic neutrophils
were recognized by their decondensed nuclei occupying practically the
whole cell volume and a reduced intensity of PI signal (Brinkmann et al.,
2013). Images were obtained using a FluoView FV1000 confocal micro-
scope (Olympus, Tokyo) equipped with a Plapon 60X/1.42 objective
and analyzed with Olympus FV10-ASW software (Olympus, France).
ROS production
Neutrophils were incubated at 37°C with PMA (Sigma-Aldrich) and VIP or
CM. Then 5 μM 2′,7′-Dichlorofluorescin diacetate (DCFH-DA) (Sigma-
Aldrich) was added for another 15min and cells analyzed by flow cytometry.
Apoptosis assay
Neutrophils were incubated for 6 or 18 h in RPMI/2% FBS, with VIP, CM
and/or lipopolysaccharide (LPS) 055:B5 (Sigma-Aldrich), and apoptosis
was assessed by flow cytometry and fluorescence microscopy. Cells were
stained with Annexin V FITC/PI for flow cytometry where 10 000 events
were acquired and results analyzed using FlowJo software (Ashland, OR,
USA). Alternatively, cells were stained with ethidium bromide and acridine
orange, and 300 cells in each condition were counted by fluorescence
microscopy.
Phagocytosis assay and assessment
of phagocytic cell profile
Apoptotic neutrophils were obtained after 18 h incubation in RPMI 1640
or CM and stained with carboxyfluorescein succinimidyl ester (CFSE) (Life
Technologies, Buenos Aires, Argentina). The percentage of apoptosis was
50% as determined by flow cytometry. Monocytes were challenged with
apoptotic neutrophils in a 1:10 ratio. After phagocytosis, monocytes were
stained with anti-CD14, and CD14/CFSE-positive cells were analyzed
Figure 2 Swan-71 and HTR8 trophoblast CM and VIP reduce reactive oxygen species (ROS) formation. Neutrophils were stimulated with PMA,
and ROS production was quantified by flow cytometry using 2′,7′-dichlorofluorescin diacetate as indicated in Materials and Methods. (A) Neutrophils
(2 × 105) were incubated for 45 min with 100 ng/ml PMA and 10 nM VIP or CM, and mean fluorescence intensity was assessed. Values are mean ±
SEM (*P < 0.05; n = 6, Kruskal–Wallis test). Representative histograms are shown. (B) Neutrophils (2 × 105) were stimulated with PMA and CM from
either Swan-71 or HTR8 trophoblast cells in the presence or absence of a VIP receptor antagonist. Representative histograms of two independent
experiments are shown.














by flow cytometry as previously described (Paparini et al., 2015).
Supernatants from CD14+ cells were collected after phagocytosis, and IL-
12 and IL-10 concentrations were determined by ELISA (OptEIA, BD
Biosciences, Franklin Lakes, NJ, USA).
Statistical analysis
The significance of the results was analyzed by the Mann–Whitney test or
the Wilcoxon test for nonparametric samples. When multiple compari-
sons were necessary, the Kruskal–Wallis test was used. Differences
between groups were considered significant at P < 0.05 using the
GraphPad Prism4 software (GraphPad, San Diego, CA, USA).
Results
CM and VIP inhibit NET formation
Neutrophils in maternal circulation, especially at the intervillous space,
are exposed to pro-inflammatory stimuli that could rapidly induce ROS
synthesis and NET formation with deleterious consequences. Based on
the immunoregulatory effects of trophoblast cells and VIP, we first
explored their effect on PMA-induced NET formation. Figure 1A upper
panel shows the characteristic structure of NETs released by neutro-
phils treated with PMA for 4 h in which DNA co-localized with elastase
either extracellularly or inside cells before they were released. NETosis
........................................................................................
Table I VIP antagonist inhibits the effect of trophoblast
CM.
ROS formation DNA release
PMA 1299 ± 204 5.1 ± 0.5
PMA + CM 935 ± 184a 3.9 ± 0.5a
PMA + CM + VIP antagonist 1410 ± 200b 5.1 ± 0.4b
Neutrophils were stimulated with phorbol myristate acetate (PMA) in the presence
or absence of trophoblast conditioned media (CM) and vasoactive intestinal poly-
peptide (VIP) receptor antagonist (50 nM) to determine reactive oxygen species
(ROS) production or DNA release as indicated in Materials and Methods. Values
are mean ± SEM (n = 3). aP < 0.05 versus PMA; bP < 0.05 versus PMA + CM
(Wilcoxon test).
Figure 3 Trophoblast CM and VIP diminish NETosis and increase apoptosis. (A) Neutrophils (1 × 106) were incubated with PMA in the presence of
10 nM VIP or Swan-71 CM for 150 min on Lab-Tek chambers as indicated in Materials and Methods. Cells were stained with PI and the percentage of
netotic, apoptotic and viable cells was determined. A representative experiment out of six run similarly is shown. (B) PI-stained neutrophils in representa-
tive images of one out of six independent experiments depicted in (A) are shown. Cropped images correspond to selected areas. Scale bars = 10 µm.














levels were reduced when PMA was added to neutrophils in the pres-
ence of 10 nM VIP or Swan-71 trophoblast cell CM. The inhibitory
effects of VIP and CM on NETosis were also assessed by measuring
DNA levels in the supernatants of neutrophils exposed to PMA
(Fig. 1B). CM reduced elastase release by PMA-stimulated neutrophils
and, although not significant, a decrease of elastase was seen with
10 nM VIP alone (Fig. 1B).
CM and VIP inhibit neutrophil ROS
formation
ROS synthesis has a major role in NET formation, so we explored the
effect of VIP and trophoblast CM on ROS synthesis by neutrophils.
Figure 2A shows that 10 nM VIP and CM from Swan-71 trophoblast
cells inhibit PMA-induced ROS formation. The effect displayed by CM
from Swan-71 cells was further assessed using another first trimester
cytotrophoblast cell line (HTR8). The antagonist of VIP receptors
reversed the inhibition of CM on ROS formation (Fig. 2B), and a similar
effect was observed for NETosis as determined by DNA release
(Table I). The effect of the VIP receptor antagonist on CM is consistent
with the presence of VIP in CM of both trophoblast cell lines, as deter-
mined by ELISA (205 ± 10 and 172 ± 51 pg/ml for Swan-71 and
HTR8, respectively) and previously shown for both cell lines
(Fraccaroli et al., 2015; Vota et al., 2016).
NETosis inhibition by CM and VIP parallels
an increase in neutrophil apoptosis
The inhibitory effect of CM or VIP on NETosis was also assessed after
a 150 min PMA treatment, where neutrophils undergoing NETosis
Figure 4 CM and VIP reverse the anti-apoptotic effect of LPS. (A) Neutrophils (5 × 105) were incubated for 6 or 18 h with 10 nM VIP or Swan-71
trophoblast CM in the presence or absence of 200 ng/ml lipopolysaccharide (LPS), and the percentage of apoptotic neutrophils was assessed as indi-
cated in Materials and Methods. Values are mean ± SEM (*P < 0.05; n = 7, Kruskal–Wallis test). (B) Representative images of apoptotic neutrophils at
18 h in each condition as depicted in (A). Scale bars = 10 µm. (C) Neutrophils (5 × 105) were incubated for 18 h with 10 nM VIP or Swan-71 CM in the
presence or absence of 200 ng/ml LPS, and the percentage of apoptotic neutrophils was assessed with Annexin/PI staining. Representative dot plots
of four independent experiments are shown.














presented intracellular chromatin decondensation but still preserved
plasma membrane integrity, and could be clearly distinguished from
apoptotic and viable nuclei. In this condition, a lower number of
NETotic cells was paralleled by an increase in apoptotic and viable cells
(Fig. 3A and B).
VIP and CM reverse the anti-apoptotic effect
of LPS
We next examined the ability of VIP and CM to accelerate spontan-
eous neutrophil apoptosis and to interfere with the anti-apoptotic
effect of LPS. LPS reduced by >50% the number of neutrophils under-
going spontaneous apoptosis and CM reversed the LPS effect, increas-
ing the number of apoptotic neutrophils at 6 and 18 h (Fig. 4A–C). VIP
reversed the LPS effect at 18 h. Of note, in the absence of LPS, CM
but not VIP alone accelerated spontaneous neutrophil apoptosis at
6 and 18 h (Fig. 4A).
CM from VIP knocked-down cells fail
to promote neutrophil apoptosis
To further test the role of VIP synthesized by trophoblast cells on neu-
trophil apoptosis, we studied spontaneous apoptosis of neutrophils
incubated for 18 h with CM from scramble siRNA (control) or from
VIP knocked-down trophoblast cells at two VIP siRNA level conditions
(50 and 100 nM). We previously demonstrated a >60% reduction in
VIP at the protein level in trophoblast cells with 100 nM siRNA (not
shown) (Vota et al., 2016). As shown in Fig. 5, CM from scramble
siRNA transfected cells (control) enhanced neutrophil apoptosis,
whereas CM from VIP-silenced cells did not modify apoptotic neutro-
phil number when compared to basal levels, suggesting a facilitating
effect of endogenous trophoblast VIP on neutrophil apoptosis.
CM promote silent phagocytosis of apoptotic
neutrophils
To assess the potential relevance of the deactivating and pro-
apoptotic effects of CM on neutrophils for homeostasis maintenance,
we analyzed its effect on apoptotic neutrophil phagocytosis by autolo-
gous monocytes (Fig. 6A). Monocytes plated overnight were then
faced for 40 min to either neutrophils undergoing spontaneous apop-
tosis (basal) or apoptosis promoted by CM. Enhanced phagocytosis
was observed when neutrophils were exposed to CM compared with
neutrophils undergoing spontaneous apoptosis at either 6 or 18 h
(Fig. 6B), being almost 40% higher at 18 h (Fig. 6C). Moreover, the
production of the pro-inflammatory cytokine IL-12 did not increase
upon phagocytosis of neutrophils cultured in the presence of CM, and
only a trend (not significant) of an increase in IL-10 was observed
(Fig. 6D).
Discussion
Neutrophils circulating through the intervillous space can become acti-
vated by placental oxidation metabolites, placental microvesicles and
IL-8, among other stimuli. So far, local regulatory mechanisms that
restrain their activation before they return to the maternal systemic
circulation are still unclear. Results presented here support that VIP
synthesized by trophoblast cells might have this role by preventing
neutrophil activation and NET formation while increasing neutrophil
apoptosis and their clearance by professional phagocytes. This conclu-
sion is based on the following observations: First, VIP and trophoblast
CM inhibited PMA-induced NET formation. The effect of trophoblast
CM on NETosis was prevented by the VIP receptor antagonist. Second,
VIP inhibited PMA-induced ROS formation, and the effect was mim-
icked by trophoblast CM containing VIP in the absence but not in the
presence of an antagonist of VIP receptors. Third, VIP and CM
enhanced neutrophil apoptosis or reversed the anti-apoptotic effect of
LPS. The pro-apoptotic effect of CM was diminished by silencing VIP in
trophoblast cells. Finally, neutrophils cultured in the presence of CM
were more efficiently engulfed by autologous monocytes without pro-
inflammatory cytokine production.
Neutrophils are short life span cells subjected to a complex network
of cell survival and death signals (Gabelloni et al., 2013). They undergo
rapid spontaneous apoptosis in the absence of survival stimuli, and
they are efficiently removed by phagocytic cells, such as macrophages
or dendritic cells, with anti-inflammatory cytokine release as a key
Figure 5 VIP knocked-down trophoblast cells do not accelerate
neutrophil apoptosis. (A) Neutrophils (5 × 105) were incubated for
18 h without (Basal) or with CM from scramble siRNA (CM scramble)
or from VIP knocked-down trophoblast cells at two VIP siRNA level
conditions (50 and 100 nM) (CM siRNA VIP 50 and CM siRNA VIP
100) as indicated. The percentage of apoptotic neutrophils was
assessed. Values are mean ± SEM of three independent experiments
(*P < 0.05, Wilcoxon test). (B) Neutrophils (5 × 105) were incubated
for 18 h with CM scramble or CM siRNA VIP 100, and apoptosis was
assessed using Annexin V/PI. Representative dot plots of two inde-
pendent experiments are shown.














mechanism in the resolution of inflammation. In contrast, neutrophils
forming NETs induce M2 alternative activated macrophages to release
pro-inflammatory mediators (Nakazawa et al., 2016). Several cytokines
including IL-8, tumor necrosis factor (TNF) and interferon (IFN)-γ can
signal to induce NETosis (Brinkmann et al., 2004; Kaplan and Radic,
2012). Both trophoblast microvesicles and IL-8 release in high amounts
by trophoblast cells were described as potential triggers of NET forma-
tion in preeclampsia (Gupta et al., 2005). Thus, it is conceivable that
placental microvesicles or the high levels of IL-8 trigger NETosis in cir-
culating neutrophils at the intervillous space and that anti-inflammatory
signals emerge locally to prevent massive NET formation. Also, high
levels of TNF and IFN-γ are detected in pregnancies complicated by
strong pathogenic or damage stimuli (Hamilton et al., 2012). These sig-
nals would increase neutrophil activation and impair pregnancy out-
come if not timely overcome by a potent local modulation.
Our results add new evidence on VIP as a factor synthesized
by trophoblast cells to modulate nearby neutrophil function. In this
regard, a deactivating effect of trophoblast cells on neutrophil oxidant
production capacity was demonstrated through an elegant design using
single-cell assays to assess cell–cell interactions (Petty et al., 2006).
ROS plays a central role in initiating the NETosis programme, as
demonstrated in patients with chronic granulomatous disease
(Papayannopoulos and Zychlinsky, 2009; Remijsen et al., 2011).
Likewise, NETosis is inhibited by ROS scavengers (Metzler et al.,
2011). The fact that VIP inhibited both ROS synthesis and NETosis
when added together with a potent stimulus like PMA and at a range
of concentrations present in trophoblast CM strongly supports that
trophoblast VIP could down-modulate neutrophil activation in vivo.
Moreover, here we showed that VIP and trophoblast CM accelerated
neutrophil spontaneous apoptosis and reversed the anti-apoptotic effect
of LPS. In support of a role of this neuropeptide in the pro-apoptotic
effect of trophoblast CM, neutrophil apoptosis decreased when neutro-
phils were incubated with VIP knocked-down trophoblast cells. VIP did
not modify caspase 3 activity in human neutrophils (Djanani and Kahler,
2002), but it accelerated neutrophil apoptosis determined with an ATP
viability assay in responsive subjects (Abdalla, 2010). It is noteworthy
that 10 nM VIP alone was not as potent as CM to promote apoptosis
and to inhibit NETosis, strongly suggesting that additional factors
released by trophoblast cells are also involved. Accordingly, knocking-
down VIP in trophoblast cells not only resulted in a reduced pro-
apoptotic effect on neutrophils but also in an impaired trophoblast
migration and interaction with monocytes (Vota et al., 2016), pointing to
the convergence of trophoblast VIP with other trophoblast mediators to
maintain homeostasis throughout pregnancy. Finally, CM increased the
amount and the rate of apoptotic neutrophil engulfment by monocytes
without IL-12 release, reinforcing the anti-inflammatory nature of the
effects elicited by trophoblast-derived factors. The present novel mech-
anismmediated by VIP might provide new clues for immune and tropho-
blast cell pharmacological targeting in pregnancy. Consistently, VIP
treatment increased anti-inflammatory mediator expression and
improved pregnancy outcome in the CBAxDBA resorption-prone
mouse model (Gallino et al., 2016). The inhibition of NET formation by
trophoblast VIP and its priming effect on neutrophil apoptosis might
reflect an active mechanism to deactivate and remove neutrophils, thus
contributing to the synergy of local signals induced at the placenta to
maintain immune homeostasis.
Figure 6 Phagocytosis of CM-induced apoptotic neutrophils by autologous monocytes. (A) Monocytes were faced to apoptotic neutrophils previ-
ously incubated for 6 or 18 h with CM or media alone as described in Material and Methods and depicted in the cartoon. (B) Monocytes (5 × 105) were
plated overnight, washed and incubated for 40 min with apoptotic neutrophils previously cultured with CM or media alone (basal), and phagocytosis was
measured as CD14 + carboxyfluorescein succinimidyl ester + double stained cells over CD14+ cells by flow cytometry. Values are the mean ± SEM of
at least five independent experiments (*P < 0.05, Mann–Whitney test). (C) Apoptotic neutrophil engulfment assessed at 18 h. Results are the mean ±
SEM of the number of donor samples shown (*P < 0.05, Mann–Whitney test). (D) After phagocytosis, CD14+ cells were incubated for an additional
24 h, and supernatants were collected for IL-12 and IL-10 measurement. Values are the mean ± SEM of at least three experiments.
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